The former Teva chairman attended the "Globes" Israel Business Conference and said, "Teva can digest another large company."
"I am completely recovered," former Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) chairman Eli Hurvitz told "Bloomberg" yesterday. Hurvitz, 77, who has always been a byword for the most successful Israeli company of all time, attended the "Globes" Israel Business Conference 2010.
Hurvitz resigned from Teva early this year, due to illness. He nevertheless continues to attract attention from the business media.
Teva is well known for its ability to absorb large and small companies, making a major acquisition on an average of every 18 months. The most recent acquisition was Germany's Ratiopharm GmbH, for $5 billion. Hurvitz said, "There is no question that Teva can digest another large company of a size like Ratiopharm."
Published by Globes [online], Israel business news - www.globes-online.com - on December 14, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010
Shiri Habib-Valdhorn, Adi Ben-Israel and Ran Rimon